Literature DB >> 12134225

Long-term follow-up of chronic hepatitis B virus infection in children of different ethnic origins.

George Marx1, Steven R Martin, Jean-Francois Chicoine, Fernando Alvarez.   

Abstract

The natural history of chronic hepatitis B in children is influenced by mode of transmission and varies with regional endemicity. Seroconversion rates were studied in 174 hepatitis B e antigen (HBeAg)-positive children who were of different ethnic origins and living in Canada. Overall, 40.2% became anti-HBeAg positive, and 8.6% were hepatitis B surface-antigen positive during a mean follow-up of 4.5 years. Spontaneous seroconversion rates were lower in Asian-born, mainly vertically infected, children, versus those born either in Canada or where horizontal transmission predominates (24% vs. 44%, P=.015). Kaplan-Meier analysis showed that the cumulative persistence of HBeAg after 13 years was 25% in Asian-born children, versus 6% in all others (P<.05). Treatment of 27 children accelerated seroconversion by 3 years, without influencing the proportion seroconverting over time. Thus, although Asian-born children seroconvert more slowly, a large proportion will seroconvert before adulthood. Because treatment appears to accelerate anti-HBe seroconversion, longitudinal studies are required in order to assess the long-term benefits of early treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12134225     DOI: 10.1086/341508

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  24 in total

1.  Chronic hepatitis B in children in the United States and Canada: international origins place the disease burden on children even in the era of universal vaccination.

Authors:  Haruki Komatsu; Ayano Inui
Journal:  Transl Pediatr       Date:  2016-01

Review 2.  Predicting survival in hepatitis B.

Authors:  M Sherman
Journal:  Gut       Date:  2005-11       Impact factor: 23.059

3.  Predictive factors of lamivudine treatment success in an hepatitis B virus-infected pediatric cohort: a 10-year study.

Authors:  Yasmine Yousef; Kathie Beland; Emmanuel Mas; Pascal Lapierre; Dorothée Bouron Dal Soglio; Fernando Alvarez
Journal:  Can J Gastroenterol       Date:  2012-07       Impact factor: 3.522

Review 4.  Natural history of chronic hepatitis B: phases in a complex relationship.

Authors:  Catherine M N Croagh; John S Lubel
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

5.  Efficacy and safety of interferon alpha-2b versus pegylated interferon alpha-2a monotherapy in children with chronic hepatitis B: a real-life cohort study from Shanghai, China.

Authors:  Yao Hu; Ying-Zi Ye; Li-Jing Ye; Xiao-Hong Wang; Hui Yu
Journal:  World J Pediatr       Date:  2019-09-05       Impact factor: 2.764

6.  The management of chronic viral hepatitis: A Canadian consensus conference 2004.

Authors:  Morris Sherman; Vincent Bain; Jean-Pierre Villeneuve; Robert P Myers; Curtis Cooper; Steven Martin; Catherine Lowe
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-11       Impact factor: 2.471

Review 7.  Chronic hepatitis B in children and adolescents: epidemiology and management.

Authors:  Mona Abdel-Hady; Deirdre Kelly
Journal:  Paediatr Drugs       Date:  2013-08       Impact factor: 3.022

8.  Characteristics of treatment naïve chronic hepatitis B in Bangladesh: younger populations are more affected; HBeAg-negatives are more advanced.

Authors:  Shanhinul Alam; Nooruddin Ahmad; Golam Mustafa; Khorshed Alam; Mobin Khan
Journal:  Saudi J Gastroenterol       Date:  2008-01       Impact factor: 2.485

Review 9.  Hepatitis B and C in Children.

Authors:  Rohan Malik; Winita Hardikar
Journal:  Indian J Pediatr       Date:  2016-04-20       Impact factor: 1.967

10.  Public health model for prevention of liver cancer among Asian Americans.

Authors:  Hee-Soon Juon; Carol Strong; Thomas H Oh; Theresa Castillo; Grace Tsai; Leslie D Hsu Oh
Journal:  J Community Health       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.